These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4382306)

  • 41. Competitive antagonism of isoprenaline-induced cardiac necroses by beta-adrenoreceptor blocking agents.
    Dorigotti L; Gaetani M; Glässer AH; Turolla E
    J Pharm Pharmacol; 1969 Mar; 21(3):188-91. PubMed ID: 4388215
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of monoamine oxidase inhibition on guanethidine-induced noradrenaline release and sympathetic blockade.
    Fielden R; Green AL
    J Pharm Pharmacol; 1965 Jul; 17(7):463-4. PubMed ID: 4379272
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacological studies on heart muscle lesions induced by isoproterenol.
    Zbinden G; Moe RA
    Ann N Y Acad Sci; 1969 Jan; 156(1):294-308. PubMed ID: 4400975
    [No Abstract]   [Full Text] [Related]  

  • 44. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs.
    Neff NH; Yang HY
    Life Sci; 1974 Jun; 14(11):2061-74. PubMed ID: 4603266
    [No Abstract]   [Full Text] [Related]  

  • 45. 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.
    Elverfors A; Pileblad E; Lagerkvist S; Bergquist F; Jonason J; Nissbrandt H
    J Neurochem; 1997 Oct; 69(4):1684-92. PubMed ID: 9326297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of reserpine on body temperature in the rat after pretreatment with amphetamine and monoamineoxidase inhibitors.
    Cremades A; Serrano JS; Jané F; Milanés MV
    Methods Find Exp Clin Pharmacol; 1982; 4(8):563-8. PubMed ID: 7169843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prevention of isoproterenol-induced myocardial necroses by lowering of the plasma calcium level with calcitonin].
    Fleckenstein A; Pachinger O; Leder O; Hein B; Janke J
    Pflugers Arch; 1972; 332():Suppl 332:R40. PubMed ID: 5066020
    [No Abstract]   [Full Text] [Related]  

  • 48. [Ultrastructural modifications induced by several drugs on adrenergic nerve endings and on the adrenal medulla].
    Clementi F
    Experientia; 1965 Mar; 21(3):171-6. PubMed ID: 5890429
    [No Abstract]   [Full Text] [Related]  

  • 49. Interaction between tyramine and iproniazid on guinea-pig atria.
    Garcia de Jalón PD; Martinez-Sierra R; Velasco A
    Br J Pharmacol; 1973 Aug; 48(4):609-11. PubMed ID: 4788204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of imipramine, desipramine and monoamine oxidase inhibitors on the metabolism and psychomotor stimulant actions of d-amphetamine in mice.
    Lew C; Iversen SD; Iversen LL
    Eur J Pharmacol; 1971 May; 14(4):351-9. PubMed ID: 4400534
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of a hydrazine monoamine oxidase inhibitor (phenelzine) on isoproterenol-induced myocardiopathies in the rat.
    Stanton HC; Schwartz A
    J Pharmacol Exp Ther; 1967 Sep; 157(3):649-58. PubMed ID: 6048021
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of lesions and drugs on brain tryptamine.
    Marsden CA; Curzon G
    J Neurochem; 1974 Dec; 23(6):1171-6. PubMed ID: 4281442
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of sympathomimetic drugs in eliciting hypertensive responses to reserpine in the rat, after pretreatment with monoamineoxidase inhibitors.
    Cashin CH
    Br J Pharmacol; 1972 Feb; 44(2):203-9. PubMed ID: 4668590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure-activity relationships of monoamine oxidase inhibitors.
    Fujita T
    J Med Chem; 1973 Aug; 16(8):923-30. PubMed ID: 4745836
    [No Abstract]   [Full Text] [Related]  

  • 56. N-methyl-n-2-propynyl-l-indanamine. A protent monoamine oxidase inhibitor.
    Huebner CF; Donoghue EM; Plummer AJ; Furness PA
    J Med Chem; 1966 Nov; 9(6):830-2. PubMed ID: 5972038
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of reserpine and monoamine oxidase inhibition on the levels of amino acids in sensory ganglia, sympathetic ganglia and spinal cord.
    Santini M; Berl S
    Brain Res; 1972 Nov; 47(1):167-76. PubMed ID: 4641266
    [No Abstract]   [Full Text] [Related]  

  • 58. SYMPATHOMIMETIC ACTIONS OF MONOAMINE OXIDASE INHIBITORS IN THE ISOLATING NICITATING MEMBRANE OF THE CAT.
    TSAI TH; FLEMING WW
    Biochem Pharmacol; 1965 Mar; 14():369-71. PubMed ID: 14314337
    [No Abstract]   [Full Text] [Related]  

  • 59. Proceedings: Age dependent recovery of rat brain MAO activity after administration of a single dose of iproniazid and pargyline.
    Sprengeler T; Rakow D; Schulze G; Christ W
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R12. PubMed ID: 1143390
    [No Abstract]   [Full Text] [Related]  

  • 60. Removal of 5-hydroxytryptamine by rat isolated lung.
    Alabaster VA; Bakhle YS
    Br J Pharmacol; 1970 Feb; 38(2):440P-441P. PubMed ID: 5417869
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.